Cary Street Partners Financial LLC Invests $553,000 in Henry Schein, Inc. (NASDAQ:HSIC)

Key Points

• Cary Street Partners Financial LLC invested approximately $553,000 in Henry Schein, Inc. (NASDAQ:HSIC) by acquiring 8,076 shares during the first quarter.
• Henry Schein reported $1.10 earnings per share for the last quarter, missing the consensus estimate by $0.09, despite revenue increasing by 3.3% year-over-year.
• Wall Street analysts have lowered price targets for Henry Schein, with the average target now at $75.58, reflecting a generally cautious outlook on the stock.

Cary Street Partners Financial LLC purchased a new position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 8,076 shares of the company's stock, valued at approximately $553,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Investment Management Corp VA ADV acquired a new stake in Henry Schein in the 4th quarter worth about $32,000. Rakuten Securities Inc. acquired a new stake in Henry Schein in the 1st quarter worth about $34,000. Whittier Trust Co. boosted its stake in Henry Schein by 714.3% in the 1st quarter. Whittier Trust Co. now owns 798 shares of the company's stock worth $55,000 after buying an additional 700 shares during the last quarter. UMB Bank n.a. boosted its stake in Henry Schein by 23.2% in the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after buying an additional 201 shares during the last quarter. Finally, Allworth Financial LP boosted its stake in Henry Schein by 24.5% in the 1st quarter. Allworth Financial LP now owns 1,178 shares of the company's stock worth $78,000 after buying an additional 232 shares during the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

HSIC has been the topic of a number of research reports. Wells Fargo & Company cut their price objective on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Robert W. Baird restated a "neutral" rating and issued a $72.00 price objective (down from $82.00) on shares of Henry Schein in a report on Monday, July 14th. Barrington Research cut their price objective on Henry Schein from $86.00 to $78.00 and set an "outperform" rating on the stock in a report on Wednesday, August 6th. Wall Street Zen downgraded Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Finally, Evercore ISI dropped their target price on Henry Schein from $78.00 to $70.00 and set an "in-line" rating on the stock in a report on Wednesday, August 6th. Nine research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $75.58.

Henry Schein Stock Up 2.1%

HSIC stock traded up $1.40 during midday trading on Tuesday, hitting $67.50. 2,751,853 shares of the company's stock were exchanged, compared to its average volume of 1,774,827. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49. The firm has a 50 day moving average price of $71.00 and a 200-day moving average price of $71.00. The stock has a market capitalization of $8.19 billion, a price-to-earnings ratio of 21.77, a price-to-earnings-growth ratio of 2.17 and a beta of 0.81.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.09). The business had revenue of $3.24 billion for the quarter, compared to analysts' expectations of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%. Henry Schein's revenue for the quarter was up 3.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.23 earnings per share. On average, analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.